Role of Rebiopsy in Relapsed Non-Small Cell Lung Cancer for Directing Oncology Treatments

Table 5

Why rebiopsy is not done in NSCLC.

(i) Not part of clinical routine
(ii) Anatomical location is difficult for biopsy
(iii) Sense of risk involved in rebiopsy
(iv) Limited number of drugs that can be directed by rebiopsy
(v) Only a few reports available in the literature